Sophie X. Deng, MD, PhD, FARVO, has stepped into the role as the new 2025-2026 Association for Research and Ophthalmology (ARVO) president. Deng has been part of ARVO for more than 20 years, is a ...

The pivotal phase 3 clinical trial is the first of 2 that will evaluate the use of DURAVYU for the treatment of wet age-related macular degeneration.

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

ARVO Foundation to give Subrata Batabyal, PhD, 2025 Carl Camras Translational Research Award Published: April 17th 2025 | Updated: May 1st 2025 RWC 2025: Companies to share data at meeting in Fort ...

Retina specialist Priya Vakharia, MD, reveals promising ANX007 trial results, showing potential to prevent vision loss in geographic atrophy.

Retina specialist Priya Vakharia, MD, reveals promising ANX007 trial results, showing potential to prevent vision loss in geographic atrophy. Priya Vakharia, MD, a retina specialist at Retina Vitreous ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Dilsher S. Dhoot, MD discusses how newer anti-VEGF treatments, particularly aflibercept 8mg, can provide improved anatomic outcomes and extended treatment intervals for patients with neovascular AMD ...

Dilsher S. Dhoot, MD, discusses how second-generation anti-VEGF therapies like aflibercept 8mg and faricimab demonstrate superior efficacy and durability in treating neovascular AMD and DME cases, ...

Dilsher S. Dhoot, MD discusses how newer anti-VEGF treatments, particularly aflibercept 8mg, can provide improved anatomic outcomes and extended treatment intervals for patients with neovascular AMD ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.